Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform



Developer of pharmaceutical drugs designed for the treatment of Irritable Bowel Syndrome with Diarrhea, Opioid Bowel Dysfunction and pain. The company focuses on the development of dimer platform technology to address the issues of visceral hypersensitivity and hypermotility in functional gastrointestinal disorders, enabling patients who have poor treatment options in the GI disease space to begin their treatment more quickly and result in a higher likelihood of a successful treatment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 50 Francisco Street
  • Suite 245
  • San Francisco, CA 94133
  • United States

+1 (415) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore OrphoMed’s full profile, request a free trial.

OrphoMed Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 28-Jun-2019 0000 Completed Product Development
1. Early Stage VC (Series A) 24-May-2017 0000 0000 0000 Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

OrphoMed Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
% Owned
Series A 000,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

OrphoMed Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ardelyx Formerly VC-backed Fremont, CA 00 00000 000000000 00000
00000 000000 Formerly VC-backed Solana Beach, CA 0 0000 00000000000 0000
0000000 0000000000 Formerly VC-backed Lexington, MA 00 000.00 00000000 000.00
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000000 00.000
00000000 000000000 Corporate Backed or Acquired Cambridge, MA 000 00000 000000000 00000
To view this company’s complete list of competitors, request access »

OrphoMed Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Mario Family Fund Other Minority 000 0000 000000 0
New Enterprise Associates Venture Capital Minority 000 0000 000000 0
Pappas Capital Venture Capital Minority 000 0000 000000 0
Relativity Healthcare Partners Venture Capital Minority 000 0000 000000 0
Takeda Ventures Corporate Venture Capital Minority 000 0000 000000 0

OrphoMed Executive Team (11)

Name Title Board
Nikhilesh Singh Ph.D Co-Founder, Chief Executive Officer, President and Board Member
Frank Steinberg Co-Founder
Lisa Turner Vice President, Clinical Operations
Gregory Beyer Vice President, Finance & Operations
Virginia Sanders Ph.D Vice President, Preclinical Development & Program Management

1 Former Executive

You’re viewing 5 of 11 executives. Get the full list »

OrphoMed Board Members (7)

Name Representing Role Since Contact
Arthur Pappas Pappas Capital Board Member 000 0000
Frank Torti MD New Enterprise Associates Board Member 000 0000
Kenneth Widder MD OrphoMed Executive Chairman 000 0000
Michael Chao MD Self Board Member 000 0000
Michael Martin Ph.D Takeda Ventures Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 7 board members. Get the full list »